A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
Clinical trial NCT01632228 · COMPLETED
Trial details
- NCT number
- NCT01632228
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-29
- Primary completion
- 2016-01-21
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.